BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36581854)

  • 1. The effects of neutral argon plasma versus electrocoagulation on tissue in advanced-stage ovarian cancer: a case series.
    Nieuwenhuyzen-de Boer GM; van de Berg NJ; Gao XS; Ewing-Graham PC; van Beekhuizen HJ
    J Ovarian Res; 2022 Dec; 15(1):140. PubMed ID: 36581854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of the PlasmaJet® Device in advanced stage ovarian carcinoma: a systematic review.
    Nieuwenhuyzen-de Boer GM; van der Kooy J; van Beekhuizen HJ
    J Ovarian Res; 2019 Jul; 12(1):71. PubMed ID: 31362769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant Use of PlasmaJet Device During Cytoreductive Surgery for Advanced-Stage Ovarian Cancer: Results of the PlaComOv-study, a Randomized Controlled Trial in The Netherlands.
    Nieuwenhuyzen-de Boer GM; Hofhuis W; Reesink-Peters N; Willemsen S; Boere IA; Schoots IG; Piek JMJ; Hofman LN; Beltman JJ; van Driel WJ; Werner HMJ; Baalbergen A; van Haaften-de Jong AMLD; Dorman M; Haans L; Nedelcu I; Ewing-Graham PC; van Beekhuizen HJ
    Ann Surg Oncol; 2022 Aug; 29(8):4833-4843. PubMed ID: 35552938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of effectiveness of the PlasmaJet surgical device in the treatment of advanced stage ovarian cancer (PlaComOv-study): study protocol of a randomized controlled trial in the Netherlands.
    Nieuwenhuyzen-de Boer GM; Hofhuis W; Reesink-Peters N; Ewing-Graham PC; Schoots IG; Beltman JJ; Piek JMJ; Baalbergen A; Kooi GS; van Haaften A; van Huisseling H; Haans L; Dorman M; van Beekhuizen HJ
    BMC Cancer; 2019 Jan; 19(1):58. PubMed ID: 30642296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost Study of the PlasmaJet Surgical Device Versus Conventional Cytoreductive Surgery in Patients With Advanced-Stage Ovarian Cancer.
    Nieuwenhuyzen-de Boer GM; Geraerds AJLM; van der Linden MH; van Doorn HC; Polinder S; van Beekhuizen HJ
    JCO Clin Cancer Inform; 2022 Sep; 6():e2200076. PubMed ID: 36198130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Emerging Role of Neutral Argon Plasma (PlasmaJet) in the Treatment of Advanced Stage Ovarian Cancer: A Systematic Review.
    Prodromidou A; Pandraklakis A; Iavazzo C
    Surg Innov; 2020 Jun; 27(3):299-306. PubMed ID: 32129144
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of the clinical and histological appearances after treatment of advanced stage ovarian cancer with PlasmaJet® device.
    Natarajan P; Martha Schofield A; Elena Vinturache A; Ruthven S; Lane S; Duncan Macdonald R
    Eur J Obstet Gynecol Reprod Biol; 2024 May; 296():311-315. PubMed ID: 38518485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microscopic, Macroscopic and Thermal Impact of Argon Plasma, Diode Laser, and Electrocoagulation on Ovarian Tissue.
    Stefanovic S; Sütterlin M; Gaiser T; Scharff C; Neumann M; Berger L; Froemmel N; Tuschy B; Berlit S
    In Vivo; 2023; 37(2):531-538. PubMed ID: 36881055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of ablation and ultrasonic aspiration at primary debulking surgery in advanced stage ovarian, fallopian tube, and primary peritoneal cancer.
    Li S; Manning-Geist B; Gockley A; Ramos A; Sisodia RC; Del Carmen M; Growdon WB; Horowitz N; Berkowitz R; Worley M
    Int J Gynecol Cancer; 2020 Jul; 30(7):1052-1057. PubMed ID: 32487686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary debulking surgery of the upper abdomen and the diaphragm, with a plasma device surgery system, for advanced ovarian cancer.
    Cordeiro Vidal G; Babin G; Querleu D; Guyon F
    Gynecol Oncol; 2017 Jan; 144(1):223-224. PubMed ID: 27836207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal cytoreduction with neutral argon plasma energy in selected patients with ovarian and primitive peritoneal cancer.
    Renaud MC; Sebastianelli A
    J Obstet Gynaecol Can; 2013 Jan; 35(1):49-52. PubMed ID: 23343797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with PlasmaJet™ in debulking surgery in 87 patients with advanced-stage ovarian cancer.
    Volcke A; Van Nieuwenhuysen E; Han S; Salihi R; Van Gorp T; Vergote I
    J Surg Oncol; 2021 Mar; 123(4):1109-1114. PubMed ID: 33497468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of PlasmaJet for Peritoneal Carcinomatosis in Ovarian Cancer.
    Panuccio E; Leunen K; Van Nieuwenhuysen E; Neven P; Lambrechts S; Vergote I
    Int J Gynecol Cancer; 2016 Oct; 26(8):1521-4. PubMed ID: 27488213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoreductive Surgery with the PlasmaJet Improved Quality-of-Life for Advanced Stage Ovarian Cancer Patients.
    Nieuwenhuyzen-de Boer GM; Aamran H; van den Berg CB; Willemsen S; Piek JMJ; Reesink-Peters N; Maliepaard M; van Doorn HC; Polinder S; van Beekhuizen HJ
    Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel technique: Carbon dioxide gas-assisted total peritonectomy, diaphragm and intestinal meso stripping in open surgery for advanced ovarian cancer (Çukurova technique).
    Khatib G; Guzel AB; Gulec UK; Vardar MA
    Gynecol Oncol; 2017 Sep; 146(3):674-675. PubMed ID: 28720378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Thermal Effects of J-Plasma®, Monopolar, Argon, and Laser Electrosurgery in a Porcine Tissue Model.
    Masghati S; Pedroso J; Gutierrez M; Stockwell E; Volker KW; Howard DL
    Surg Technol Int; 2019 May; 34():35-39. PubMed ID: 30825320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparison of Thermal Plasma Energy Versus Argon Beam Coagulator-Induced Intestinal Injury After Vaporization in a Porcine Model.
    Tanner EJ; Dun E; Sonoda Y; Olawaiye AB; Chi DS
    Int J Gynecol Cancer; 2017 Jan; 27(1):177-182. PubMed ID: 27922979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interval debulking surgery following neo-adjuvant chemotherapy for stage IVB ovarian cancer using neutral argon plasma (PlasmaJet™).
    Butler-Manuel S; Lippiatt J; Madhuri TK
    Gynecol Oncol; 2014 Dec; 135(3):622-3. PubMed ID: 25450152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncologic outcomes after splenectomy during initial cytoreductive surgery in advanced epithelial ovarian cancer: a nationwide population-based cohort study.
    Said SA; van der Aa MA; Veldmate G; de Hullu JA; van Altena AM
    Acta Obstet Gynecol Scand; 2022 Jan; 101(1):56-67. PubMed ID: 34719790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and outcomes after bowel surgery and ostomy formation at the time of debulking surgery for advanced-stage epithelial ovarian carcinoma.
    Gockley AA; Fiascone S; Hicks Courant K; Pepin K; Del Carmen M; Clark RM; Goldberg J; Horowitz N; Berkowitz R; Worley M
    Int J Gynecol Cancer; 2019 Mar; 29(3):585-592. PubMed ID: 30833444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.